Metabolic Reprogramming of Leukemia Stem Cells as a Novel Therapeutic Target for Relapsed Acute Myeloid Leukemia. Pakistan Journal of Medical & Cardiological Review, [S. l.], v. 5, n. 1, p. 5786–5812, 2026. DOI: 10.5281/zenodo.22067075. Disponível em: https://pakjmcr.com/index.php/1/article/view/1698. Acesso em: 1 sep. 2026.